OTC Pharmaceuticals Top 5 Emerging Markets Industry Guide_2016

Date: October 18, 2016
Pages: 134
Price:
US$ 995.00
License [?]:
Publisher: MarketLine
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: O9C4F27B7CDEN
Leaflet:

Download PDF Leaflet

OTC Pharmaceuticals Top 5 Emerging Markets Industry Guide_2016
SUMMARY

The Emerging 5 OTC Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2011-15, and forecast to 2020). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

KEY FINDINGS
  • Save time carrying out entry-level research by identifying the size, growth, major segments, and leading players in the emerging five otc pharmaceuticals market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the emerging five otc pharmaceuticals market
  • Leading company profiles reveal details of key otc pharmaceuticals market players' emerging five operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the emerging five otc pharmaceuticals market with five year forecasts by both value and volume
  • Compares data from Brazil, China, India, Mexico and South Africa, alongside individual chapters on each country
SYNOPSIS

Essential resource for top-line data and analysis covering the emerging five otc pharmaceuticals market. Includes market size and segmentation data, textual and graphical analysis of market growth trends and leading companies.

REASONS TO BUY
  • What was the size of the emerging five otc pharmaceuticals market by value in 2015?
  • What will be the size of the emerging five otc pharmaceuticals market in 2020?
  • What factors are affecting the strength of competition in the emerging five otc pharmaceuticals market?
  • How has the market performed over the last five years?
  • Who are the top competitors in the emerging five otc pharmaceuticals market?
KEY HIGHLIGHTS
  • These countries contributed $27,938.9 million to the global otc pharmaceuticals industry in 2015, with a compound annual growth rate (CAGR) of 6.8% between 2007 and 2011. The top 5 emerging countries are expected to reach a value of $38,099.3 million in 2020, with a CAGR of 6.4% over the 2015-20 period.
  • Within the otc pharmaceuticals industry, China is the leading country among the top 5 emerging nations, with market revenues of $19,005.3 million in 2015. This was followed by Brazil and India with a value of $4,381.0 and $2,062.7 million, respectively.
  • China is expected to lead the otc pharmaceuticals industry in the top five emerging nations, with a value of $25,516.5 million in 2020, followed by Brazil and India with expected values of $6,200.1 and $3,252.5 million, respectively.
Introduction
What is this report about?
Who is the target reader?
How to use this report
Definitions
Top Emerging Countries OTC Pharmaceuticals
Industry Outlook
OTC Pharmaceuticals in South Africa
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Brazil
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in China
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in India
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
OTC Pharmaceuticals in Mexico
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Company Profiles
Leading companies
Appendix
Methodology
About MarketLine

LIST OF TABLES

Table 1: Top 5 emerging countries otc pharmaceuticals industry, revenue ($m), 2011-20
Table 2: Top 5 emerging countries otc pharmaceuticals industry, revenue ($m), 2011-15
Table 3: Top 5 emerging countries otc pharmaceuticals industry forecast, revenue ($m), 2015-20
Table 4: South Africa OTC pharmaceuticals market value: $ million, 2011-15
Table 5: South Africa OTC pharmaceuticals market category segmentation: $ million, 2015
Table 6: South Africa OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 7: South Africa OTC pharmaceuticals market share: % share, by value, 2015
Table 8: South Africa OTC pharmaceuticals market distribution: % share, by value, 2015
Table 9: South Africa OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 10: South Africa size of population (million), 2011-15
Table 11: South Africa gdp (constant 2005 prices, $ billion), 2011-15
Table 12: South Africa gdp (current prices, $ billion), 2011-15
Table 13: South Africa inflation, 2011-15
Table 14: South Africa consumer price index (absolute), 2011-15
Table 15: South Africa exchange rate, 2011-15
Table 16: Brazil OTC pharmaceuticals market value: $ million, 2011-15
Table 17: Brazil OTC pharmaceuticals market category segmentation: $ million, 2015
Table 18: Brazil OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 19: Brazil OTC pharmaceuticals market share: % share, by value, 2015
Table 20: Brazil OTC pharmaceuticals market distribution: % share, by value, 2015
Table 21: Brazil OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 22: Brazil size of population (million), 2011-15
Table 23: Brazil gdp (constant 2005 prices, $ billion), 2011-15
Table 24: Brazil gdp (current prices, $ billion), 2011-15
Table 25: Brazil inflation, 2011-15
Table 26: Brazil consumer price index (absolute), 2011-15
Table 27: Brazil exchange rate, 2011-15
Table 28: China OTC pharmaceuticals market value: $ million, 2011-15
Table 29: China OTC pharmaceuticals market category segmentation: $ million, 2015
Table 30: China OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 31: China OTC pharmaceuticals market share: % share, by value, 2015
Table 32: China OTC pharmaceuticals market distribution: % share, by value, 2015
Table 33: China OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 34: China size of population (million), 2011-15
Table 35: China gdp (constant 2005 prices, $ billion), 2011-15
Table 36: China gdp (current prices, $ billion), 2011-15
Table 37: China inflation, 2011-15
Table 38: China consumer price index (absolute), 2011-15
Table 39: China exchange rate, 2011-15
Table 40: India OTC pharmaceuticals market value: $ million, 2011-15
Table 41: India OTC pharmaceuticals market category segmentation: $ million, 2015
Table 42: India OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 43: India OTC pharmaceuticals market share: % share, by value, 2015
Table 44: India OTC pharmaceuticals market distribution: % share, by value, 2015
Table 45: India OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 46: India size of population (million), 2011-15
Table 47: India gdp (constant 2005 prices, $ billion), 2011-15
Table 48: India gdp (current prices, $ billion), 2011-15
Table 49: India inflation, 2011-15
Table 50: India consumer price index (absolute), 2011-15
Table 51: India exchange rate, 2011-15
Table 52: Mexico OTC pharmaceuticals market value: $ million, 2011-15
Table 53: Mexico OTC pharmaceuticals market category segmentation: $ million, 2015
Table 54: Mexico OTC pharmaceuticals market geography segmentation: $ million, 2015
Table 55: Mexico OTC pharmaceuticals market share: % share, by value, 2015
Table 56: Mexico OTC pharmaceuticals market distribution: % share, by value, 2015
Table 57: Mexico OTC pharmaceuticals market value forecast: $ million, 2015-20
Table 58: Mexico size of population (million), 2011-15
Table 59: Mexico gdp (constant 2005 prices, $ billion), 2011-15
Table 60: Mexico gdp (current prices, $ billion), 2011-15
Table 61: Mexico inflation, 2011-15
Table 62: Mexico consumer price index (absolute), 2011-15
Table 63: Mexico exchange rate, 2011-15
Table 64: Adcock Ingram Holdings Limited: key facts
Table 65: Adcock Ingram Holdings Limited: key financials ($)
Table 66: Adcock Ingram Holdings Limited: key financials (ZAR)
Table 67: Adcock Ingram Holdings Limited: key financial ratios
Table 68: Pharma Natura (Pty) Ltd.: key facts
Table 69: Reckitt Benckiser Group plc: key facts
Table 70: Reckitt Benckiser Group plc: key financials ($)
Table 71: Reckitt Benckiser Group plc: key financials (£)
Table 72: Reckitt Benckiser Group plc: key financial ratios
Table 73: Weleda AG: key facts
Table 74: Abbott Laboratories: key facts
Table 75: Abbott Laboratories: key financials ($)
Table 76: Abbott Laboratories: key financial ratios
Table 77: GlaxoSmithKline Plc: key facts
Table 78: GlaxoSmithKline Plc: key financials ($)
Table 79: GlaxoSmithKline Plc: key financials (£)
Table 80: GlaxoSmithKline Plc: key financial ratios
Table 81: Johnson and Johnson: key facts
Table 82: Johnson and Johnson: key financials ($)
Table 83: Johnson and Johnson: key financial ratios
Table 84: Sanofi SA: key facts
Table 85: Sanofi SA: key financials ($)
Table 86: Sanofi SA: key financials (€)
Table 87: Sanofi SA: key financial ratios
Table 88: Huangshan Tianmu Pharmaceutical Co., Ltd.: key facts
Table 89: Nin Jiom Medicines Manufactory Ltd: key facts
Table 90: Cipla Limited: key facts
Table 91: Cipla Limited: key financials ($)
Table 92: Cipla Limited: key financials (Rs.)
Table 93: Cipla Limited: key financial ratios
Table 94: Dabur India Limited: key facts
Table 95: Dabur India Limited: key financials ($)
Table 96: Dabur India Limited: key financials (Rs.)
Table 97: Dabur India Limited: key financial ratios
Table 98: Bayer AG: key facts
Table 99: Bayer AG: key financials ($)
Table 100: Bayer AG: key financials (€)
Table 101: Bayer AG: key financial ratios
Table 102: Bristol Myers Squibb Company: key facts
Table 103: Bristol Myers Squibb Company: key financials ($)
Table 104: Bristol Myers Squibb Company: key financial ratios
Table 105: Royal DSM N.V.: key facts
Table 106: Royal DSM N.V.: key financials ($)
Table 107: Royal DSM N.V.: key financials (€)
Table 108: Royal DSM N.V.: key financial ratios

LIST OF FIGURES

Figure 1: Top 5 emerging countries otc pharmaceuticals industry, revenue ($m), 2011-20
Figure 2: Top 5 emerging countries otc pharmaceuticals industry, revenue ($m), 2011-15
Figure 3: Top 5 emerging countries otc pharmaceuticals industry forecast, revenue ($m), 2015-20
Figure 4: South Africa OTC pharmaceuticals market value: $ million, 2011-15
Figure 5: South Africa OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 6: South Africa OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 7: South Africa OTC pharmaceuticals market share: % share, by value, 2015
Figure 8: South Africa OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 9: South Africa OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 10: Forces driving competition in the OTC pharmaceuticals market in South Africa, 2015
Figure 11: Drivers of buyer power in the OTC pharmaceuticals market in South Africa, 2015
Figure 12: Drivers of supplier power in the OTC pharmaceuticals market in South Africa, 2015
Figure 13: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in South Africa, 2015
Figure 14: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in South Africa, 2015
Figure 15: Drivers of degree of rivalry in the OTC pharmaceuticals market in South Africa, 2015
Figure 16: Brazil OTC pharmaceuticals market value: $ million, 2011-15
Figure 17: Brazil OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 18: Brazil OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 19: Brazil OTC pharmaceuticals market share: % share, by value, 2015
Figure 20: Brazil OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 21: Brazil OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 22: Forces driving competition in the OTC pharmaceuticals market in Brazil, 2015
Figure 23: Drivers of buyer power in the OTC pharmaceuticals market in Brazil, 2015
Figure 24: Drivers of supplier power in the OTC pharmaceuticals market in Brazil, 2015
Figure 25: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Brazil, 2015
Figure 26: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Brazil, 2015
Figure 27: Drivers of degree of rivalry in the OTC pharmaceuticals market in Brazil, 2015
Figure 28: China OTC pharmaceuticals market value: $ million, 2011-15
Figure 29: China OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 30: China OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 31: China OTC pharmaceuticals market share: % share, by value, 2015
Figure 32: China OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 33: China OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 34: Forces driving competition in the OTC pharmaceuticals market in China, 2015
Figure 35: Drivers of buyer power in the OTC pharmaceuticals market in China, 2015
Figure 36: Drivers of supplier power in the OTC pharmaceuticals market in China, 2015
Figure 37: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in China, 2015
Figure 38: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in China, 2015
Figure 39: Drivers of degree of rivalry in the OTC pharmaceuticals market in China, 2015
Figure 40: India OTC pharmaceuticals market value: $ million, 2011-15
Figure 41: India OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 42: India OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 43: India OTC pharmaceuticals market share: % share, by value, 2015
Figure 44: India OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 45: India OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 46: Forces driving competition in the OTC pharmaceuticals market in India, 2015
Figure 47: Drivers of buyer power in the OTC pharmaceuticals market in India, 2015
Figure 48: Drivers of supplier power in the OTC pharmaceuticals market in India, 2015
Figure 49: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in India, 2015
Figure 50: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in India, 2015
Figure 51: Drivers of degree of rivalry in the OTC pharmaceuticals market in India, 2015
Figure 52: Mexico OTC pharmaceuticals market value: $ million, 2011-15
Figure 53: Mexico OTC pharmaceuticals market category segmentation: % share, by value, 2015
Figure 54: Mexico OTC pharmaceuticals market geography segmentation: % share, by value, 2015
Figure 55: Mexico OTC pharmaceuticals market share: % share, by value, 2015
Figure 56: Mexico OTC pharmaceuticals market distribution: % share, by value, 2015
Figure 57: Mexico OTC pharmaceuticals market value forecast: $ million, 2015-20
Figure 58: Forces driving competition in the OTC pharmaceuticals market in Mexico, 2015
Figure 59: Drivers of buyer power in the OTC pharmaceuticals market in Mexico, 2015
Figure 60: Drivers of supplier power in the OTC pharmaceuticals market in Mexico, 2015
Figure 61: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in Mexico, 2015
Figure 62: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in Mexico, 2015
Figure 63: Drivers of degree of rivalry in the OTC pharmaceuticals market in Mexico, 2015
Figure 64: Adcock Ingram Holdings Limited: revenues and profitability
Figure 65: Adcock Ingram Holdings Limited: assets and liabilities
Figure 66: Reckitt Benckiser Group plc: revenues and profitability
Figure 67: Reckitt Benckiser Group plc: assets and liabilities
Figure 68: Abbott Laboratories: revenues and profitability
Figure 69: Abbott Laboratories: assets and liabilities
Figure 70: GlaxoSmithKline Plc: revenues and profitability
Figure 71: GlaxoSmithKline Plc: assets and liabilities
Figure 72: Johnson and Johnson: revenues and profitability
Figure 73: Johnson and Johnson: assets and liabilities
Figure 74: Sanofi SA: revenues and profitability
Figure 75: Sanofi SA: assets and liabilities
Figure 76: Cipla Limited: revenues and profitability
Figure 77: Cipla Limited: assets and liabilities
Figure 78: Dabur India Limited: revenues and profitability
Figure 79: Dabur India Limited: assets and liabilities
Figure 80: Bayer AG: revenues and profitability
Figure 81: Bayer AG: assets and liabilities
Figure 82: Bristol Myers Squibb Company: revenues and profitability
Figure 83: Bristol Myers Squibb Company: assets and liabilities
Figure 84: Royal DSM N.V.: revenues and profitability
Figure 85: Royal DSM N.V.: assets and liabilities
Skip to top


Ask Your Question

OTC Pharmaceuticals Top 5 Emerging Markets Industry Guide_2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: